Short answer
Ingevity Corp (NGVT) filed its Q2 2026 10-Q quarterly report on Jul 30, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $314M (down 14.0% year over year) with net income of $35M.
Q2 2026 key financials · XBRL
- Revenue
- $314M
- −14.0% YoY · +21.7% QoQ
- Net income
- $35M
- +124.1% YoY · −41.0% QoQ
- Gross margin
- 44.3%
- EPS (diluted)
- $1.01
- +125.1% YoY · −39.2% QoQ
Source: XBRL data from the Ingevity Corp (NGVT) Q2 2026 10-Q on SEC EDGAR. USD.
Ingevity Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Content limited to MD&A introduction; no quarterly revenue or YoY comparison disclosed
- No profitability, margin, segment, cash flow, capital deployment, or outlook figures disclosed
Risk Factors
- No material changes to 2025 Annual Report risk factors except intellectual-property litigation exposure
- Intellectual-property enforcement costs and adverse rulings threatening financial condition and operating results
- Third-party infringement claims potentially requiring substantial damages or product injunctions
- China manufacturing increasing risk of proprietary-technology misappropriation
- Trade-secret breaches potentially reducing revenues, margins, and market share
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ingevity Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.